Skip to main content

R-Biopharm Gets CE Mark for SARS-CoV-2 PCR Test

NEW YORK – R-Biopharm of Darmstadt, Germany, has obtained the CE mark for its SARS-CoV-2 real-time RT-PCR test.

The company's Rida Gene SARS-CoV-2 test is designed for the qualitative detection of SARS-CoV-2 RNA from throat and nasopharyngeal swabs of individuals with respiratory symptoms. It runs on the Roche LightCycler 480II and is intended for use by professionals in hospital, reference, private, and state laboratories.

R-Biopharm develops tests for clinical diagnostics and food analysis. The company was founded in 1988 as a subsidiary of Röhm and was spun out in 1991. It has subsidiaries in the US, UK, Italy, France, the Netherlands, Latin America, Brazil, Spain, Belgium, Australia, and China.